In new research, Xuelin Li, Sijie Wang, Jiajie Xu, and Xiang Zheng find that the involvement of specialized venture capital firms influences a biotech startup’s drug portfolio by focusing research and development on fewer products.
Source link
Related
Discover more from Digi Ads Traffic | Expert Digital Marketing & Targeted Advertising Solutions
Subscribe to get the latest posts sent to your email.
About us and this blog
We are a digital marketing company with a focus on helping our customers achieve great results across several key areas.
Subscribe to our newsletter!
More from our blog
See all posts
The AI startup Perplexity AI is reportedly in late-stage talks to raise…
What if you could instantly tell whether a study was trustworthy without…
Many top language models now err on the side of caution, refusing…
ChatGPT is more than just a prompting and response platform. You can…
This post was sponsored by RollerAds. The opinions expressed in this article…
One thing I need you to understand about the groundbreaking data I’m…
Researchers have tested a method for rewriting blocked prompts in text-to-video systems…
Over the last year, the United States government has demonstrated increased concern…
No Comments
Recent Posts
- Is Perplexity AI Really Worth $14 Billion? May 15, 2025
- Scite AI Review: Instantly Spot Trustworthy Studies May 15, 2025
- Getting Language Models to Open Up on ‘Risky’ Subjects May 14, 2025
All Website Tags
Advanced LLMs
advertising
AI chips
AI hallucinations
AI image
AI Image Editing
AI legal
AI search
AI video
AI video creation
anomaly detection
antitrust and competition
AR
automated data labelling
best of
Biology
censorship
China
coding
data augmentation
digital marketing
FBI warning
google
Grok 3
increase website traffic
Interview
Language Model
Llama 3
LLM
Meta
movies
nvidia
perplexity
Protect Gmail
responsive
Robotics
SEO
social media
social media traffic
Stigler Center 2025 Antitrust and Competition Conference
text to video models
TikTok Ban
video
video diffusion
winston ai
